CP 375 is primarily utilized in the field of pharmaceutical research and development. It is often investigated for its potential therapeutic properties, particularly in the treatment of neurological disorders. Researchers explore its efficacy in modulating specific biochemical pathways that are implicated in conditions such as anxiety, depression, and other mood-related illnesses. Additionally, CP 375 is studied for its potential role in enhancing cognitive functions, making it a candidate for addressing cognitive impairments associated with neurodegenerative diseases. Its application extends to preclinical studies where it is used to understand its pharmacokinetics, safety profile, and overall biological activity, paving the way for potential clinical trials and therapeutic use.